Materias:

Tabla de Contenidos: “…Audit Planning: A Risk-Based Approach; CONTENTS; PREFACE; LIST OF ABBREVIATIONS; Chapter 1: WHY RISK-BASED AUDIT PLANNING?…”

Tabla de Contenidos: “…Cover; Nanotechnology Risk, Ethics and Law; Copyright; Contents; List of Figures, Tables and Boxes; List of Contributors; Preface and Acknowledgements; List of Acronyms and Abbreviations; Chapter 1 Introduction: The Challenge of Nanotechnologies; History; The nanoscale; Nanotechnology in society; Regional economic forces; Ethical? …”

“…Inside the risk management and corporate governance issues behind capital structure decisions Practical ways of determining capital structures have always been mysterious and riddled with risks and uncertainties. …”

Materias:

Materias:

Materias:

“…Providing a simple foundational remedy for our security ills, Security De-Engineering: Solving the Problems in Information Risk Management is a definitive guide to the current problems impacting corporate information risk management. …”

Tabla de Contenidos: “…Front Cover; The Science and Technology of Counterterrorism: Measuring Physical and Electronic Security Risk; Copyright; Dedication; Contents; Acknowledgments; About the Author; Preface; Part I: Modeling Terrorism Risk; Chapter 1: Terrorism Threats, Risk, and Risk Assessments; 1.1. …”

Tabla de Contenidos: “…Introduction -- Risk-based monitoring: basic concepts -- Risk-based monitoring: customizing the review experience -- Detecting fraud at the clinical site -- Detectign patient fraud -- Snapshot comparisons -- Final thoughts…”

Tabla de Contenidos: “…Intro -- FrontMatter -- Reviewers -- Preface -- Contents -- Abstract -- Summary -- 1 Introduction -- 2 Guiding Principles for Sharing Clinical Trial Data -- 3 The Roles and Responsibilities of Stakeholders in the Sharing of Clinical Trial Data -- 4 The Clinical Trial Life Cycle and When to Share Data -- 5 Access to Clinical Trial Data: Governance -- 6 The Future of Data Sharing in a Changing Landscape -- Appendix A: Study Approach -- Appendix B: Concepts and Methods for De-identifying Clinical Trial Data -- Appendix C: Legal Discussion of Risks to Industry Sponsors -- Appendix D: Clinical Trial Data Sharing Policies: Top 1-12 Pharmaceutical Companies Ranked by 2013 Market Capitalization -- Appendix E: Biosketches of Committee Members…”

Tabla de Contenidos: “…Cover -- The Edge of Sentience : Risk and Precaution in Humans, Other Animals, and AI -- Copyright -- Dedication -- Epigraph -- Contents -- List of Illustrations -- Summary of the Framework and Proposals -- Precautionary Framework -- Proposals about Specific Cases -- People with Disorders of Consciousness -- Human Fetuses and Embryos -- Human Neural Organoids -- Other Animals -- Artificial Intelligence (AI) -- 1: A Walk along the Edge -- 1.1 The Unmarked Border -- 1.2 Decision Points -- 1.3 When to Stop? …”